Pyramax®: Way forward for "real-life" effective malaria treatment

29 and 30 Jun 2021
Join MMV and partner, Shin Poong Pharm for a webinar to learn more about the results of the largest real-life study of Pyramax® (pyronaridine-artesunate) for the treatment of uncomplicated malaria in Africa. 
Register for the webinar in English on 29th June (2:30 PM GMT+2) and in French on 30th June (2:30 PM GMT+2). 

Stephan Duparc

MMV's Chief Medical Officer, Dr Stephan Duparc will be speaking at this event.